Intercity spread of gonococci with decreased susceptibility to fluoroquinolones: A unique focus in the United States

Journal of Infectious Diseases

Volumn 177, Issue 3, 1998, Pages 677-682

  Kilmarx, Peter H ^a,b,c   Knapp, Joan S ^e   Xia, Minsheng ^d   St Louis, Michael E ^e   Neal, Sandra W ^e   Sayers, Dennis ^e   Doyle, Laura J ^e   Roberts, Marilyn C ^e   Whittington, William L ^d  

^a MINISTRY OF PUBLIC HEALTH   (Thailand)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c HIV/AIDS Collaboration   (Thailand)

^d UNIVERSITY OF WASHINGTON   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; GONORRHEA; HUMAN; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; PREVALENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SEXUAL BEHAVIOR; UNITED STATES;

EID: 0031934734     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514234     Document Type: Article

References (31)

1. Echols RM, Heyd A, O'Keeffe BJ, Schacht P. Single-dose ciprofloxacin for the treatment of uncomplicated gonorrhea: a worldwide summary. Sex Transm Dis 1994;21:345-52.
2. Moran JS, Levine WC. Drugs of choice for the treatment of uncomplicated gonococcal infections. Clin Infect Dis 1995;20(suppl 1):S47-65.
3. CDC. 1993 sexually transmitted diseases treatment guidelines. MMWR Morb Mortal Wkly Rep 1993;42(RR-14):I-102.
4. Tapsall JW, Shultz TR, Lovett R, Munro R. Failure of 500 mg ciprofloxacin therapy in male urethral gonorrhea [letter]. Med J Australia 1992;156:143.
5. Bogaerts J, Tello WM, Akingeneye J, Mukantabana V, Van Dyck E, Piot P. Effectiveness of norfloxacin and ofloxacin for treatment of gonorrhea and decrease of in vitro susceptibility to quinolones over time in Rwanda. Genitourin Med 1993;69:196-200.
6. Gransden WR, Warren CA, Philip I. 4-quinolone-resistant Neisseria gonorrhoeae in the United Kingdom. J Med Microbiol 1991;34:23-7.
7. Birley H, McDonald P, Carey P. High-level ciprofloxacin resistance in Neisseria gonorrhoeae. Genitourin Med 1994;70:292-3.
8. Jephcott AE, Turner A. Ciprofloxacin resistance in gonococci [letter]. Lancet 1990;335:165.
9. O'Mahoney C, Timmins D. Treatment failure using double dose ciprofloxacin in a case of highly resistant gonorrhea. Genitourin Med 1992;68:274-5.
10. CDC. Fluoroquinolone resistance in Neisseria gonorrhoeae - Colorado and Washington, 1995. MMWR Morb Mortal Wkly Rep 1995;44:761-4.
11. Knapp JS, Hale JA, Winterscheid K, Neal SW, Whittington WL. Proposed criteria for the interpretation of susceptibilities of strains of Neisseria gonorrhoeae to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, and norfloxacin. Antimicrob Agents Chemother 1995;39:2442-5.
12. Belland RJ, Morrison SG, Ison C, Huang WM. Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates. Mol Microbiol 1994;14:371-80.
13. Gorwitz RJ, Nakashima AK, Moran JS, Knapp JS. Sentinel surveillance for antimicrobial resistance in Neisseria gonorrhoeae - United States, 1988-1991. MMWR CDC Surveill Summ 1993;42(SS-3):29-39.
14. CDC. Decreased susceptibility of Neisseria gonorrhoeae to fluoroquinolones - Ohio and Hawaii, 1992-94. MMWR Morb Mortal Wkly Rep 1994;43:325-7.
15. Knapp JS, Washington JA, Doyle LJ, Neal SW, Parekh MC, Rice RJ. Persistence of Neisseria gonorrhoeae strains with decreased susceptibilities to ciprofloxacin and ofloxacin in Cleveland, Ohio, from 1992 through 1993. Antimicrob Agents Chemother 1994;38:2194-6.
16. Gordon SM, Carlyn CJ, Doyle LJ, Knapp CC, Longworth DL, Hall GS, et al. The emergence of Neisseria gonorrhoeas with decreased susceptibility to ciprofloxacin in Cleveland, Ohio: epidemiology and risk factors. Ann Intern Med 1996;125:465-70.
17. Knapp JS, Rice RJ. Neisseria and Brahamella. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. 6th ed. Washington, DC: American Society for Microbiology, 1996:324-40.
18. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A3. Villanova, PA: NCCLS, 1993.
19. Knapp JS, Tam MR, Nowinski RC, Holmes KK, Sandstrom EG. Serologic classification of Neisseria gonorrhoeae with use of monoclonal antibodies to gonococcal outer membrane protein I. J Infect Dis 1984;150:44-8.
20. Xia M, Whittington WL, Holmes KK, Plummer FA, Roberts MC. Pulsed-field gel electrophoresis for genomic analysis of Neisseria gonorrhoeae. J Infect Dis 1995;171:455-8.
21. Xia M, Roberts MR, Whittington WL, et al. Neisseria gonorrhoeae with decreased susceptibility to ciprofloxacin: pulsed-field gel electrophoresis typing of strains from North America, Hawaii, and the Philippines. Antimicrob Agents Chemother 1996;40:2439-40.
22. Gottlieb DJ, Beiser AS, O'Connor GT. Poverty, race, and medication use are correlates of asthma hospitalization rates. A small area analysis in Boston. Chest 1995;108:28-35.
23. Division of STD Prevention, Centers for Disease Control and Prevention. Sexually transmitted disease surveillance, 1995. Atlanta: CDC, 1996.
24. Clendennen TE, Hames CS, Kees ES, et al. In vitro antibiotic susceptibilities of Neisseria gonorrhoeae isolates from the Philippines. Antimicrob Agents Chemother 1992;36:277-82.
25. Yeung KH, Dillon JR. Norfloxacin resistant Neisseria gonorrhoeae in North America [letter]. Lancet 1990;336:759.
26. Tapsall JW, Schultz TR, Phillips EA. Characteristics of Neisseria gonorrhoeae isolated in Australia showing decreased sensitivity to quinolone antibiotics. Pathology 1992;24:27-31.
27. Poh CL, Loh GK, Tapsall JW. Resolution of clonal subgroups among Neisseria gonorrhoeas IB-2 and IB-6 serovars by pulsed-field gel electrophoresis. Genitourin Med 1995;71:145-9.
28. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233-9.
29. Knapp JS, Holmes KK, Bonin P, Hook EW. Epidemiology of gonorrhea: distribution and temporal changes of auxotype/serovar classes of Neisseria gonorrhoeas. Sex Transm Dis 1987;14:26-32.
30. Yeung KH, Pauze M, Hickey S, Dillon JR. Prevalence and strain type of antibiotic-resistant Neisseria gonorrhoeae isolates in Canada [abstract 304]. In: Abstract monograph: 11th meeting of the International Society for STD Research (New Orleans). International Society for STD Research, 1995.
31. Hook EW, Brady WE, Reichart CA, Upchurch DM, Sherma LA, Wasserheit JN. Determinants of emergence of antibiotic-resistant Neisseria gonorrhoeae. J Infect Dis 1989;159:900-7.